The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Antivenom Serum-Global Market Insights and Sales Trends 2024
Synopsis
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
The global Antivenom Serum market size is expected to reach US$ 1209.7 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antivenom Serum in various end use industries. The expanding demands from the Monovalent and Polyvalent, are propelling Antivenom Serum market. Humans, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Animals segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antivenom Serum, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antivenom Serum market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antivenom Serum market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antivenom Serum sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antivenom Serum covered in this report include Merck, Summerland Serums (AU), Haffkine Bio Pharmaceutical, MicroPharm, CSL (AU), SAVP, Flynn Pharma and Serum, etc.
The global Antivenom Serum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Summerland Serums (AU)
Haffkine Bio Pharmaceutical
MicroPharm
CSL (AU)
SAVP
Flynn Pharma
Serum
Global Antivenom Serum market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antivenom Serum market, Segment by Type:
Humans
Animals
Global Antivenom Serum market, by Application
Monovalent
Polyvalent
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antivenom Serum manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antivenom Serum in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Antivenom, also known as antivenin, venom antiserum and antivenom immunoglobulin, is a medication made from antibodies which is used to treat certain venomous bites and stings. They are only recommended if there is significant toxicity or a high risk of toxicity. The specific antivenom needed depends on the species involved. It is given by injection.
The global Antivenom Serum market size is expected to reach US$ 1209.7 million by 2029, growing at a CAGR of 3.3% from 2023 to 2029. The market is mainly driven by the significant applications of Antivenom Serum in various end use industries. The expanding demands from the Monovalent and Polyvalent, are propelling Antivenom Serum market. Humans, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Animals segment is estimated at % CAGR for the next seven-year period.
The global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Antivenom Serum, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Antivenom Serum market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Antivenom Serum market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Antivenom Serum sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Antivenom Serum covered in this report include Merck, Summerland Serums (AU), Haffkine Bio Pharmaceutical, MicroPharm, CSL (AU), SAVP, Flynn Pharma and Serum, etc.
The global Antivenom Serum market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Merck
Summerland Serums (AU)
Haffkine Bio Pharmaceutical
MicroPharm
CSL (AU)
SAVP
Flynn Pharma
Serum
Global Antivenom Serum market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Antivenom Serum market, Segment by Type:
Humans
Animals
Global Antivenom Serum market, by Application
Monovalent
Polyvalent
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Antivenom Serum manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Antivenom Serum in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Antivenom Serum Market Overview
1.1 Antivenom Serum Product Overview
1.2 Antivenom Serum Market Segment by Type
1.2.1 Humans
1.2.2 Animals
1.3 Global Antivenom Serum Market Size by Type
1.3.1 Global Antivenom Serum Market Size Overview by Type (2018-2029)
1.3.2 Global Antivenom Serum Historic Market Size Review by Type (2018-2023)
1.3.3 Global Antivenom Serum Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Antivenom Serum Sales Breakdown by Type (2018-2023)
1.4.2 Europe Antivenom Serum Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Antivenom Serum Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Antivenom Serum Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Antivenom Serum Sales Breakdown by Type (2018-2023)
2 Global Antivenom Serum Market Competition by Company
2.1 Global Top Players by Antivenom Serum Sales (2018-2023)
2.2 Global Top Players by Antivenom Serum Revenue (2018-2023)
2.3 Global Top Players by Antivenom Serum Price (2018-2023)
2.4 Global Top Manufacturers Antivenom Serum Manufacturing Base Distribution, Sales Area, Product Type
2.5 Antivenom Serum Market Competitive Situation and Trends
2.5.1 Antivenom Serum Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Antivenom Serum Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Antivenom Serum as of 2022)
2.7 Date of Key Manufacturers Enter into Antivenom Serum Market
2.8 Key Manufacturers Antivenom Serum Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Antivenom Serum Status and Outlook by Region
3.1 Global Antivenom Serum Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Antivenom Serum Historic Market Size by Region
3.2.1 Global Antivenom Serum Sales in Volume by Region (2018-2023)
3.2.2 Global Antivenom Serum Sales in Value by Region (2018-2023)
3.2.3 Global Antivenom Serum Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Antivenom Serum Forecasted Market Size by Region
3.3.1 Global Antivenom Serum Sales in Volume by Region (2024-2029)
3.3.2 Global Antivenom Serum Sales in Value by Region (2024-2029)
3.3.3 Global Antivenom Serum Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Antivenom Serum by Application
4.1 Antivenom Serum Market Segment by Application
4.1.1 Monovalent
4.1.2 Polyvalent
4.2 Global Antivenom Serum Market Size by Application
4.2.1 Global Antivenom Serum Market Size Overview by Application (2018-2029)
4.2.2 Global Antivenom Serum Historic Market Size Review by Application (2018-2023)
4.2.3 Global Antivenom Serum Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Antivenom Serum Sales Breakdown by Application (2018-2023)
4.3.2 Europe Antivenom Serum Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Antivenom Serum Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Antivenom Serum Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Antivenom Serum Sales Breakdown by Application (2018-2023)
5 North America Antivenom Serum by Country
5.1 North America Antivenom Serum Historic Market Size by Country
5.1.1 North America Antivenom Serum Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Antivenom Serum Sales in Volume by Country (2018-2023)
5.1.3 North America Antivenom Serum Sales in Value by Country (2018-2023)
5.2 North America Antivenom Serum Forecasted Market Size by Country
5.2.1 North America Antivenom Serum Sales in Volume by Country (2024-2029)
5.2.2 North America Antivenom Serum Sales in Value by Country (2024-2029)
6 Europe Antivenom Serum by Country
6.1 Europe Antivenom Serum Historic Market Size by Country
6.1.1 Europe Antivenom Serum Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Antivenom Serum Sales in Volume by Country (2018-2023)
6.1.3 Europe Antivenom Serum Sales in Value by Country (2018-2023)
6.2 Europe Antivenom Serum Forecasted Market Size by Country
6.2.1 Europe Antivenom Serum Sales in Volume by Country (2024-2029)
6.2.2 Europe Antivenom Serum Sales in Value by Country (2024-2029)
7 Asia-Pacific Antivenom Serum by Region
7.1 Asia-Pacific Antivenom Serum Historic Market Size by Region
7.1.1 Asia-Pacific Antivenom Serum Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Antivenom Serum Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Antivenom Serum Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Antivenom Serum Forecasted Market Size by Region
7.2.1 Asia-Pacific Antivenom Serum Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Antivenom Serum Sales in Value by Region (2024-2029)
8 Latin America Antivenom Serum by Country
8.1 Latin America Antivenom Serum Historic Market Size by Country
8.1.1 Latin America Antivenom Serum Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Antivenom Serum Sales in Volume by Country (2018-2023)
8.1.3 Latin America Antivenom Serum Sales in Value by Country (2018-2023)
8.2 Latin America Antivenom Serum Forecasted Market Size by Country
8.2.1 Latin America Antivenom Serum Sales in Volume by Country (2024-2029)
8.2.2 Latin America Antivenom Serum Sales in Value by Country (2024-2029)
9 Middle East and Africa Antivenom Serum by Country
9.1 Middle East and Africa Antivenom Serum Historic Market Size by Country
9.1.1 Middle East and Africa Antivenom Serum Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Antivenom Serum Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Antivenom Serum Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Antivenom Serum Forecasted Market Size by Country
9.2.1 Middle East and Africa Antivenom Serum Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Antivenom Serum Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Merck
10.1.1 Merck Company Information
10.1.2 Merck Introduction and Business Overview
10.1.3 Merck Antivenom Serum Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Merck Antivenom Serum Products Offered
10.1.5 Merck Recent Development
10.2 Summerland Serums (AU)
10.2.1 Summerland Serums (AU) Company Information
10.2.2 Summerland Serums (AU) Introduction and Business Overview
10.2.3 Summerland Serums (AU) Antivenom Serum Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Summerland Serums (AU) Antivenom Serum Products Offered
10.2.5 Summerland Serums (AU) Recent Development
10.3 Haffkine Bio Pharmaceutical
10.3.1 Haffkine Bio Pharmaceutical Company Information
10.3.2 Haffkine Bio Pharmaceutical Introduction and Business Overview
10.3.3 Haffkine Bio Pharmaceutical Antivenom Serum Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Haffkine Bio Pharmaceutical Antivenom Serum Products Offered
10.3.5 Haffkine Bio Pharmaceutical Recent Development
10.4 MicroPharm
10.4.1 MicroPharm Company Information
10.4.2 MicroPharm Introduction and Business Overview
10.4.3 MicroPharm Antivenom Serum Sales, Revenue and Gross Margin (2018-2023)
10.4.4 MicroPharm Antivenom Serum Products Offered
10.4.5 MicroPharm Recent Development
10.5 CSL (AU)
10.5.1 CSL (AU) Company Information
10.5.2 CSL (AU) Introduction and Business Overview
10.5.3 CSL (AU) Antivenom Serum Sales, Revenue and Gross Margin (2018-2023)
10.5.4 CSL (AU) Antivenom Serum Products Offered
10.5.5 CSL (AU) Recent Development
10.6 SAVP
10.6.1 SAVP Company Information
10.6.2 SAVP Introduction and Business Overview
10.6.3 SAVP Antivenom Serum Sales, Revenue and Gross Margin (2018-2023)
10.6.4 SAVP Antivenom Serum Products Offered
10.6.5 SAVP Recent Development
10.7 Flynn Pharma
10.7.1 Flynn Pharma Company Information
10.7.2 Flynn Pharma Introduction and Business Overview
10.7.3 Flynn Pharma Antivenom Serum Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Flynn Pharma Antivenom Serum Products Offered
10.7.5 Flynn Pharma Recent Development
10.8 Serum
10.8.1 Serum Company Information
10.8.2 Serum Introduction and Business Overview
10.8.3 Serum Antivenom Serum Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Serum Antivenom Serum Products Offered
10.8.5 Serum Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Antivenom Serum Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Antivenom Serum Industrial Chain Analysis
11.4 Antivenom Serum Market Dynamics
11.4.1 Antivenom Serum Industry Trends
11.4.2 Antivenom Serum Market Drivers
11.4.3 Antivenom Serum Market Challenges
11.4.4 Antivenom Serum Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Antivenom Serum Distributors
12.3 Antivenom Serum Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
